Hypoxic up-regulation of erythroid 5-aminolevulinate synthase

Blood

Volumn 101, Issue 1, 2003, Pages 348-350

  Hofer, Thomas ^a,b,c   Wenger, Roland H ^a,b,c   Kramer, Marianne F ^a,b,c   Ferreira, Gloria C ^a,b,c   Gassmann, Max ^a,b,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; ISOENZYME; MESSENGER RNA; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; BIOSYNTHESIS; CELL HYPOXIA; CONTROLLED STUDY; DNA BINDING; ERYTHROID CELL; ERYTHROPOIESIS; GENE CONSTRUCT; GENETIC TRANSFECTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IRON DEPLETION; IRON THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0037217941     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0773     Document Type: Article

References (25)

1. May BK, Bhasker CR, Bawden MJ, Cox TC. Molecular regulation of 5-aminolevulinate synthase: Diseases related to heme biosynthesis. Mol Biol Med. 1990;7:405-421.
2. Bishop DF, Henderson AS, Astrin KH. Human delta-aminolevulinate synthase: Assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics. 1990;7:207-214.
3. Meguro K, Igarashi K, Yamamoto M, Fujita H, Sassa S. The role of the erythroid-specific delta-aminolevulinate synthase gene expression in erythroid heme synthesis. Blood. 1995;86:940-948.
4. Cotter PD, Baumann M, Bishop DF. Enzymatic defect in "X-linked" sideroblastic anemia: Molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A. 1992;89:4028-4032.
5. Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388to-Ser substitution in erythroid 5-aminolevulinate synthase. N Engl J Med. 1994;330:675-679.
6. Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol. 1999;31:1111-1137.
7. Sadlon TJ, Dell'Oso T, Surinya KH, May BK. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis. Int J Biochem Cell Biol. 1999;31:1153-1167.
8. Rolfs A, Kvietikova I, Gassmann M, Wenger RH. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem. 1997;272:20055-20062.
9. Lok CN, Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem. 1999;274:24147-24152.
10. Mukhopadhyay CK, Mazumder B, Fox PL. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem. 2000;275:21048-21054.
11. 2-regulated gene expression. FASEB J. 2002;16:1151-1162.
12. Kramer MF, Gunaratne P, Ferreira GC. Transcriptional regulation of the murine erythroid-specific 5-aminolevulinate synthase gene. Gene. 2000;247:153-166.
13. Hofer T, Desbaillets I, Hopfl G, Gassmann M, Wenger RH. Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1α activation cascade: Implications for HIF-1α gene therapy. FASEB J. 2001;15:2715-2717.
14. Wanner RM, Spielmann P, Stroka DM, et al. Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood. 2000;96:1558-1565.
15. Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood. 1993;82:3610-3615.
16. Kvietikova I, Wenger RH, Marti HH, Gassmann M. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res. 1995;23:4542-4550.
17. Bichet S, Wenger RH, Camenisch G, et al. Oxygen tension modulates β-globin switching in embryoid bodies. FASEB J. 1999;13:285-295.
18. Ferreira GC, Dailey HA. Expression of mammalian 5-aminolevulinate synthase in Escherichia coli: overproduction, purification, and characterization. J Biol Chem. 1993;268:584-590
19. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem. 1995;270:29083-29089.
20. Surinya KH, Cox TC, May BK. Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem. 1998;273:16798-16809.
21. Wenger RH, Rolfs A, Kvietikova I, Spielmann P, Zimmermann DR, Gassmann M. The mouse gene for hypoxia-inducible factor-1α: Genomic organization, expression and characterization of an alternative first exon and 5′ flanking sequence. EurJ Biochem. 1997;246:155-165.
22. Dong Z, Venkatachalam MA, Wang J, et al. Upregulation of apoptosis inhibitory protein IAP-2 by hypoxia: Hif-1-independent mechanisms. J Biol Chem. 2001;276:18702-18709.
23. Hehlgans T, Seitz C, Lewis C, Mannel DN. Hypoxic upregulation of TNF receptor type 2 expression involves NF-IL-6 and is independent of HIF-1 or HIF-2. J Interferon Cytokine Res. 2001;21:757-762.
24. Gray NK, Hentze MW. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J. 1994;13:3882-3891.
25. Camenisch G, Tini M, Chilov D, et al. General applicability of chicken egg yolk antibodies: The performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1α. FASEB J. 1999;13:81-88.